A Prospective, Multicenter Exploratory Clinical Study on Consolidation Therapy With Tislelizumab Combined With Nintedanib for Limited-stage Small Cell Lung Cancer
Clinical trial NCT07485920 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07485920
- Sponsor
- The Affiliated Hospital of Qingdao University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-01
- Primary completion
- 2028-12-10
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.